CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 138, Issue 6, 2007, Pages 721-732

  Willimott, Shaun ^a   Baou, Maria ^a   Naresh, Kikkeri ^a   Wagner, Simon D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Bcl x S; Bcl xL; Chronic lymphocytic leukaemia

Indexed keywords

CD40 LIGAND; FLUDARABINE; INTERLEUKIN 4; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BCL XS; PROTEIN BID; PROTEIN NOXA; STAUROSPORINE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FIBROBLAST; GENE LOCUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; L CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CD40 LIGAND; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; MICE; NEOPLASM PROTEINS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAUROSPORINE; TUMOR CELLS, CULTURED; VIDARABINE;

EID: 34548153718     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06717.x     Document Type: Article

References (64)

1. Allen, R.C., Armitage, R.J., Conley, M.E., Rosenblatt, H., Jenkins, N.A., Copeland, N.G., Bedell, M.A., Edelhoff, S., Disteche, C.M., Simoneaux, D.K. Fanslow, W.C., Belmont, J. Spriggs, M.K. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science, 259, 990 993.
2. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M., Roberts, R.L., Noelle, R.J., Ledbetter, J.A., Francke, U. Ochs, H.D. (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell, 72, 291 300.
3. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F. Saeland, S. (1994) The CD40 antigen and its ligand. Annual Review of Immunology, 12, 881 922.
4. Becattini, B., Kitada, S., Leone, M., Monosov, E., Chandler, S., Zhai, D., Kipps, T.J., Reed, J.C. Pellecchia, M. (2004) Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L). Chem Biol, 11, 389 395.
5. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. Thompson, C.B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597 608.
6. Certo, M., Del Gaizo Moore, V., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S.A. Letai, A. (2006) Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell, 9, 351 365.
7. Chalfant, C., Rathman, K., Pinkerman, R., Wood, R., Obeid, L., Ogretmen, B. Hannun, Y. (2002) De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Journal of Biological Chemistry, 277, 12587 12595.
8. Chen, L., Apgar, J., Huynh, L., Dicker, F., Giago-McGahan, T., Rassenti, L., Weiss, A. Kipps, T.J. (2005a) ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood, 105, 2036 2041.
9. Chen, L., Willis, S.N., Wei, A., Smith, B.J., Fletcher, J.I., Hinds, M.G., Colman, P.M., Day, C.L., Adams, J.M. Huang, D.C.S. (2005b) Differential targeting of pro-survival BCL-2 proteins by their BH3-only ligands allows complementary apoptotic function. Molecular Cell, 17, 393 403.
10. Chiorazzi, N., Rai, K.R. Ferrarini, M. (2005) Chronic lymphocytic leukemia. New England Journal of Medicine, 352, 804 815.
11. Chu, P., Deforce, D., Pedersen, I.M., Kim, Y., Kitada, S., Reed, J.C. Kipps, T.J. (2002) Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 3854 3859.
12. Cordone, I., Matutes, E. Catovsky, D. (1992) Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia, 6, 902 906.
13. Cory, S. Adams, J.M. (2005) Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell, 8, 5 6.
14. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840 1847.
15. van Delft, M.F., Wei, A.H., Mason, K.D., Vandenberg, C.J., Chen, L., Czabotar, P.E., Willis, S.N., Scott, C.L., Day, C.L., Cory, S., Adams, J.M., Roberts, A.W. Huang, D.C. (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell, 10, 389 399.
16. Dicker, F., Kater, A.P., Fukuda, T. Kipps, T.J. (2005) Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells. Blood, 105, 3193 3198.
17. Dicker, F., Kater, A.P., Prada, C.E., Fukuda, T., Castro, J.E., Sun, G., Wang, J.Y. Kipps, T.J. (2006) CD154 induces P73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional P53. Blood, 108, 3450 3457.
18. DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A. de Saint Basile, G. (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature, 361, 541 543.
19. Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S. Volkmann, M., Galle, P., Poustka, A., Hunstein, W. Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580 1589.
20. Dohner, H., Stilgenbauer, S., James, M.R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W. Lichter, P. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 2516 2522.
21. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 1910 1916.
22. Fluckiger, A.C., Rossi, J.F., Bussel, A., Bryon, P., Banchereau, J. Defrance, T. (1992) Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood, 80, 3173 3181.
23. Galonek, H.L. Hardwick, J.M. (2006) Upgrading the BCL-2 network. Nature Cell Biology, 8, 1317 1319.
24. Ghia, P., Guida, G., Stella, S., Gottardi, D., Geuna, M., Strola, G., Scielzo, C. Caligaris-Cappio, F. (2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood, 101, 1262 1269.
25. Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., Montagna, L., Piccoli, P., Chilosi, M. Caligaris-Cappio, F. (2001) Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood, 97, 2777 2783.
26. Green, D.R. (2006) At the gates of death. Cancer Cell, 9, 328 330.
27. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848 1854.
28. Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. Oscier, D.G. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99, 1023 1029.
29. Huang, D.C., O'Reilly, L.A., Strasser, A. Cory, S. (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO Journal, 16, 4628 4638.
30. Jaksic, O., Paro, M.M., Kardum Skelin, I., Kusec, R., Pejsa, V. Jaksic, B. (2004) CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow. Blood, 103, 1968 1969.
31. Kater, A.P., Evers, L.M., Remmerswaal, E.B., Jaspers, A., Oosterwijk, M.F., van Lier, R.A., van Oers, M.H. Eldering, E. (2004) CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack. British Journal of Haematology, 127, 404 415.
32. Kim, H., Rafiuddin-Shah, M., Tu, H.C., Jeffers, J.R., Zambetti, G.P., Hsieh, J.J. Cheng, E.H. (2006) Hierarchical regulation of mitochondrion- dependent apoptosis by BCL-2 subfamilies. Nature Cell Biology, 8, 1348 1358.
33. Kitada, S., Zapata, J.M., Andreeff, M. Reed, J.C. (1999) Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 106, 995 1004.
34. Kitada, S., Monosov, E., Chandler, S., Avery, E.D., Kipps, T.J., Rosenberg, S.H. Reed, J.C. (2004) Pro-apoptotic effects on chronic lymphocytic leukaemia of ABT-737 a novel fully synthetic BCL-2/BCL-XL antagonist. Blood, 104 (A952).
35. Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P.P., Kitada, S., Deng, X., Zhai, D., Shi, Y.X., Sneed, T., Verhaegen, M., Soengas, M., Ruvolo, V.R., McQueen, T., Schober, W.D., Watt, J.C., Jiffar, T., Ling, X., Marini, F.C., Harris, D., Dietrich, M., Estrov, Z., McCubrey, J., May, W.S., Reed, J.C. Andreeff, M. (2006) Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell, 10, 375 388.
36. Korthauer, U., Graf, D., Mages, H.W., Briere, F., Padayachee, M., Malcolm, S., Ugazio, A.G., Notarangelo, L.D., Levinsky, R.J. Kroczek, R.A. (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature, 361, 539 541.
37. Lampert, I.A., Wotherspoon, A., van Noorden, S. Hasserjian, R.P. (1999) High expression of CD23 in the proliferation centres of chronic lymphocytic leukaemia in lymph nodes and spleen. Human Pathology, 30, 648 654.
38. MacCarthy-Morrogh, L., Wood, L., Brimmell, M., Johnson, P.W. Packham, G. (2000) Identification of a novel human BCL-X promoter and exon. Oncogene, 19, 5534 5538.
39. Mackus, W.J., Kater, A.P., Grummels, A., Evers, L.M., Hooijbrink, B., Kramer, M.H., Castro, J.E., Kipps, T.J., van Lier, R.A., van Oers, M.H. Eldering, E. (2005) Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation. Leukemia, 19, 427 434.
40. Massiello, A., Roesser, J. Chalfant, C. (2006) SAP155 binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA. FASEB Journal, 20, 1680 1682.
41. Mazel, S., Burtrum, D. Petrie, H. (1996) Regulation of cell division cycle progression by Bcl-2 expression: a potential mechanism for inhibition of programmed cell death. Journal of Experimental Medicine, 183, 2219 2226.
42. Messmer, B., Messmer, D., Allen, S., Kolitz, J., Kudalkar, P., Cesar, D., Murphy, E., Koduru, P., Ferrarini, M., Zupo, S., Cutrona, G., Damle, R., Wasil, T., Rai, K., Hellerstein, M. Chiorazzi, N. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukaemia B cells. Journal of Clinical Investigation, 115, 755 764.
43. Nonoyama, S., Hollenbaugh, D., Aruffo, A., Ledbetter, J.A. Ochs, H.D. (1993) B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. Journal of Experimental Medicine, 178, 1097 1102.
44. O'Reilly, L.A., Huang, D.C. Strasser, A. (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO Journal, 15, 6979 6990.
45. O'Reilly, L.A., Harris, A., Tarlinton, D., Corcoran, L. Strasser, A. (1997) Expression of a Bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. Journal of Immunology, 159, 2301 2311.
46. Oltersdorf, T., Elmore, S.W., Shoemaker, A.R., Armstrong, R.C., Augeri, D.J., Belli, B.A., Bruncko, M., Deckwerth, T.L., Dinges, J., Hajduk, P.J., Joseph, M.K., Kitada, S., Korsmeyer, S.J., Kunzer, A.R., Letai, A., Li, C., Mitten, M.J., Nettesheim, D.G., Ng, S., Nimmer, P.M., O'Connor, J.M., Oleksijew, A., Petros, A.M., Reed, J.C., Shen, W., Tahir, S.K., Thompson, C.B., Tomaselli, K.J., Wang, B., Wendt, M.D., Zhang, H., Fesik, S.W. Rosenberg, S.H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature, 435, 677 681.
47. Orchard, J.A., Ibbotson, R.E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P.W., Hamblin, T.J., Staudt, L.M. Oscier, D.G. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet, 363, 105 111.
48. Paronetto, M., Achsel, T., Massiello, A., Chalfant, C. Sette, C. (2007) The RNA binding protein Sam68 modulates the alternative splicing of Bcl-x. Journal of Cell Biology, 176, 929 939.
49. Pedersen, I.M., Kitada, S., Leoni, L.M., Zapata, J.M., Karras, J.G., Tsukada, N., Kipps, T.J., Choi, Y.S., Bennett, F. Reed, J.C. (2002) Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of MCL-1. Blood, 100, 1795 1801.
50. Pepper, C., Thomas, A., Hoy, T., Cotter, F. Bentley, P. (1999) Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 107, 611 615.
51. Petlickovski, A., Laurenti, L., Li, X., Marietti, S., Chiusolo, P., Sica, S., Leone, G. Efremov, D.G. (2005) Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood, 105, 4820 4827.
52. Pettitt, A.R., Sherrington, P.D., Stewart, G., Cawley, J.C., Taylor, A.M. Stankovic, T. (2001) p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood, 98, 814 822.
53. Puthalakath, H., Huang, D.C., O'Reilly, L.A., King, S.M. Strasser, A. (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Molecular Cell, 3, 287 296.
54. Puthalakath, H., Villunger, A., O'Reilly, L.A., Beaumont, J.G., Coultas, L., Cheney, R.E., Huang, D.C. Strasser, A. (2001) Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science, 293, 1829 1832.
55. Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New England Journal of Medicine, 351, 893 901.
56. Ratech, H., Sheibani, K., Nathwani, B.N. Rappaport, H. (1988) Immunoarchitecture of the "pseudofollicles" of well-differentiated (small) lymphocytic lymphoma: a comparison with true follicles. Human Pathology, 19, 89 94.
57. Schena, M., Larsson, L.G., Gottardi, D., Gaidano, G., Carlsson, M., Nilsson, K. Caligaris-Cappio, F. (1992) Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood, 79, 2981 2989.
58. Smit, L.A., Hallaert, D.Y., Spijker, R., de Goeij, B., Jaspers, A., Kater, A.P., van Oers, M.H., van Noesel, C.J. Eldering, E. (2006) Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood.
59. Soma, L.A., Craig, F.E. Swerdlow, S.H. (2006) The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Human Pathology, 37, 152 159.
60. Taylor, J.K., Zhang, Q.Q., Wyatt, J.R. Dean, N.M. (1999) Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nature Biotechnology, 17, 1097 1100.
61. de Totero, D., Tazzari, P., Capaia, M., Montera, M., Clavio, M., Balleari, E., Foa, R. Gobbi, M. (2003) CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukaemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gamma and tumor necrosis factor receptor-I-II upregulation. Haematologica, 88, 148 158.
62. Villunger, A., Michalak, E.M., Coultas, L., Mullauer, F., Bock, G., Ausserlechner, M.J., Adams, J.M. Strasser, A. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science, 302, 1036 1038.
63. Wiestner, A., Rosenwald, A., Barry, T.S., Wright, G., Davis, R.E., Henrickson, S.E., Zhao, H., Ibbotson, R.E., Orchard, J.A., Davis, Z., Stetler-Stevenson, M., Raffeld, M., Arthur, D.C., Marti, G.E., Wilson, W.H., Hamblin, T.J., Oscier, D.G. Staudt, L.M. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood, 101, 4944 4951.
64. Willimott, S., Baou, M., Huf, S. Wagner, S. (2007) Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukaemia. Leukemia and Lymphoma (in press).